blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3263098

EP3263098 - DELIVERY SYSTEM FOR PERCUTANEOUS ABSORPTION DRUG AND METHOD FOR MANUFACTURING SAME [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  13.05.2022
Database last updated on 03.06.2024
FormerThe patent has been granted
Status updated on  12.06.2021
FormerGrant of patent is intended
Status updated on  03.02.2021
FormerExamination is in progress
Status updated on  11.01.2021
FormerGrant of patent is intended
Status updated on  15.09.2020
FormerExamination is in progress
Status updated on  12.11.2019
FormerRequest for examination was made
Status updated on  01.12.2017
FormerThe international publication has been made
Status updated on  22.08.2017
Most recent event   Tooltip27.04.2024Lapse of the patent in a contracting state
New state(s): MK		published on 29.05.2024  [2024/22]
Applicant(s)For all designated states
MEDRx Co., Ltd.
431-7 Nishiyama
Higashikagawa-shi
Kagawa 769-2712 / JP
[2018/01]
Inventor(s)01 / HAMAMOTO, Hidetoshi
c/o MEDRX Co., Ltd.
431-7
Nishiyama
Higashikagawa-shi Kagawa 769-2712 / JP
 [2021/27]
Former [2018/01]01 / HAMAMOTO, Hidetoshi
c/o MEDRX Co. Ltd.
431-7
Nishiyama
Higashikagawa-shi Kagawa 769-2712 / JP
Representative(s)Yeadon IP Limited
Nexus
Discovery Way
Leeds LS2 3AA / GB
[2021/27]
Former [2018/01]Yeadon IP Limited
Leeds Innovation Centre
103 Clarendon Road
Leeds LS2 9DF / GB
Application number, filing date16755476.523.02.2016
[2018/01]
WO2016JP55246
Priority number, dateJP2015003380624.02.2015         Original published format: JP 2015033806
[2018/01]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016136732
Date:01.09.2016
Language:JA
[2016/35]
Type: A1 Application with search report 
No.:EP3263098
Date:03.01.2018
Language:EN
[2018/01]
Type: B1 Patent specification 
No.:EP3263098
Date:07.07.2021
Language:EN
[2021/27]
Search report(s)International search report - published on:JP01.09.2016
(Supplementary) European search report - dispatched on:EP27.09.2018
ClassificationIPC:A61K9/70
[2018/44]
CPC:
A61F13/02 (EP,US); B32B7/06 (US); A61K9/7007 (US);
A61K9/703 (EP,US); A61K9/7084 (EP,US); A61P25/02 (EP);
A61P25/20 (EP); A61P29/00 (EP); A61P9/08 (EP);
A61P9/12 (EP); B32B7/12 (US); A61M2207/00 (US);
B32B2535/00 (US) (-)
Former IPC [2018/01]A61K9/70, A61F13/02
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/01]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:FREISETZUNGSSYSTEM FÜR WIRKSTOFF ZUR PERKUTANEN ABSORPTION SOWIE VERFAHREN ZUR HERSTELLUNG DAVON[2018/01]
English:DELIVERY SYSTEM FOR PERCUTANEOUS ABSORPTION DRUG AND METHOD FOR MANUFACTURING SAME[2018/01]
French:SYSTÈME D'ADMINISTRATION POUR MÉDICAMENT À ABSORPTION PERCUTANÉE ET SON PROCÉDÉ DE FABRICATION[2018/01]
Entry into regional phase21.08.2017Translation filed 
21.08.2017National basic fee paid 
21.08.2017Search fee paid 
21.08.2017Designation fee(s) paid 
21.08.2017Examination fee paid 
Examination procedure21.08.2017Examination requested  [2018/01]
21.08.2017Date on which the examining division has become responsible
25.04.2019Amendment by applicant (claims and/or description)
15.11.2019Despatch of a communication from the examining division (Time limit: M04)
20.03.2020Reply to a communication from the examining division
16.09.2020Communication of intention to grant the patent
22.12.2020Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
04.02.2021Communication of intention to grant the patent
28.05.2021Fee for grant paid
28.05.2021Fee for publishing/printing paid
28.05.2021Receipt of the translation of the claim(s)
Opposition(s)08.04.2022No opposition filed within time limit [2022/24]
Fees paidRenewal fee
22.02.2018Renewal fee patent year 03
21.02.2019Renewal fee patent year 04
24.02.2020Renewal fee patent year 05
22.02.2021Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU23.02.2016
AL07.07.2021
AT07.07.2021
CY07.07.2021
CZ07.07.2021
DK07.07.2021
EE07.07.2021
FI07.07.2021
HR07.07.2021
LT07.07.2021
LV07.07.2021
MC07.07.2021
MK07.07.2021
NL07.07.2021
PL07.07.2021
RO07.07.2021
RS07.07.2021
SE07.07.2021
SI07.07.2021
SK07.07.2021
SM07.07.2021
BG07.10.2021
NO07.10.2021
GR08.10.2021
IS07.11.2021
PT08.11.2021
IE23.02.2022
LU23.02.2022
BE28.02.2022
CH28.02.2022
LI28.02.2022
[2024/22]
Former [2024/20]HU23.02.2016
AL07.07.2021
AT07.07.2021
CY07.07.2021
CZ07.07.2021
DK07.07.2021
EE07.07.2021
FI07.07.2021
HR07.07.2021
LT07.07.2021
LV07.07.2021
MC07.07.2021
NL07.07.2021
PL07.07.2021
RO07.07.2021
RS07.07.2021
SE07.07.2021
SI07.07.2021
SK07.07.2021
SM07.07.2021
BG07.10.2021
NO07.10.2021
GR08.10.2021
IS07.11.2021
PT08.11.2021
IE23.02.2022
LU23.02.2022
BE28.02.2022
CH28.02.2022
LI28.02.2022
Former [2024/18]HU23.02.2016
AL07.07.2021
AT07.07.2021
CZ07.07.2021
DK07.07.2021
EE07.07.2021
FI07.07.2021
HR07.07.2021
LT07.07.2021
LV07.07.2021
MC07.07.2021
NL07.07.2021
PL07.07.2021
RO07.07.2021
RS07.07.2021
SE07.07.2021
SI07.07.2021
SK07.07.2021
SM07.07.2021
BG07.10.2021
NO07.10.2021
GR08.10.2021
IS07.11.2021
PT08.11.2021
IE23.02.2022
LU23.02.2022
BE28.02.2022
CH28.02.2022
LI28.02.2022
Former [2023/10]AL07.07.2021
AT07.07.2021
CZ07.07.2021
DK07.07.2021
EE07.07.2021
FI07.07.2021
HR07.07.2021
LT07.07.2021
LV07.07.2021
MC07.07.2021
NL07.07.2021
PL07.07.2021
RO07.07.2021
RS07.07.2021
SE07.07.2021
SI07.07.2021
SK07.07.2021
SM07.07.2021
BG07.10.2021
NO07.10.2021
GR08.10.2021
IS07.11.2021
PT08.11.2021
IE23.02.2022
LU23.02.2022
BE28.02.2022
CH28.02.2022
LI28.02.2022
Former [2023/09]AL07.07.2021
AT07.07.2021
CZ07.07.2021
DK07.07.2021
EE07.07.2021
FI07.07.2021
HR07.07.2021
LT07.07.2021
LV07.07.2021
MC07.07.2021
NL07.07.2021
PL07.07.2021
RO07.07.2021
RS07.07.2021
SE07.07.2021
SI07.07.2021
SK07.07.2021
SM07.07.2021
BG07.10.2021
NO07.10.2021
GR08.10.2021
IS07.11.2021
PT08.11.2021
IE23.02.2022
LU23.02.2022
CH28.02.2022
LI28.02.2022
Former [2022/47]AL07.07.2021
AT07.07.2021
CZ07.07.2021
DK07.07.2021
EE07.07.2021
FI07.07.2021
HR07.07.2021
LT07.07.2021
LV07.07.2021
MC07.07.2021
NL07.07.2021
PL07.07.2021
RO07.07.2021
RS07.07.2021
SE07.07.2021
SI07.07.2021
SK07.07.2021
SM07.07.2021
BG07.10.2021
NO07.10.2021
GR08.10.2021
IS07.11.2021
PT08.11.2021
LU23.02.2022
Former [2022/44]AL07.07.2021
AT07.07.2021
CZ07.07.2021
DK07.07.2021
EE07.07.2021
FI07.07.2021
HR07.07.2021
LT07.07.2021
LV07.07.2021
MC07.07.2021
NL07.07.2021
PL07.07.2021
RO07.07.2021
RS07.07.2021
SE07.07.2021
SI07.07.2021
SK07.07.2021
SM07.07.2021
BG07.10.2021
NO07.10.2021
GR08.10.2021
IS07.11.2021
PT08.11.2021
Former [2022/29]AL07.07.2021
AT07.07.2021
CZ07.07.2021
DK07.07.2021
EE07.07.2021
FI07.07.2021
HR07.07.2021
LT07.07.2021
LV07.07.2021
NL07.07.2021
PL07.07.2021
RO07.07.2021
RS07.07.2021
SE07.07.2021
SI07.07.2021
SK07.07.2021
SM07.07.2021
BG07.10.2021
NO07.10.2021
GR08.10.2021
IS07.11.2021
PT08.11.2021
Former [2022/25]AT07.07.2021
CZ07.07.2021
DK07.07.2021
EE07.07.2021
FI07.07.2021
HR07.07.2021
LT07.07.2021
LV07.07.2021
NL07.07.2021
PL07.07.2021
RO07.07.2021
RS07.07.2021
SE07.07.2021
SK07.07.2021
SM07.07.2021
BG07.10.2021
NO07.10.2021
GR08.10.2021
IS07.11.2021
PT08.11.2021
Former [2022/24]AT07.07.2021
CZ07.07.2021
DK07.07.2021
EE07.07.2021
FI07.07.2021
HR07.07.2021
LT07.07.2021
LV07.07.2021
NL07.07.2021
PL07.07.2021
RO07.07.2021
RS07.07.2021
SE07.07.2021
SK07.07.2021
BG07.10.2021
NO07.10.2021
GR08.10.2021
IS07.11.2021
PT08.11.2021
Former [2022/21]AT07.07.2021
DK07.07.2021
FI07.07.2021
HR07.07.2021
LT07.07.2021
LV07.07.2021
NL07.07.2021
PL07.07.2021
RS07.07.2021
SE07.07.2021
BG07.10.2021
NO07.10.2021
GR08.10.2021
IS07.11.2021
PT08.11.2021
Former [2022/11]AT07.07.2021
FI07.07.2021
HR07.07.2021
LT07.07.2021
LV07.07.2021
NL07.07.2021
PL07.07.2021
RS07.07.2021
SE07.07.2021
BG07.10.2021
NO07.10.2021
GR08.10.2021
IS07.11.2021
PT08.11.2021
Former [2022/09]AT07.07.2021
FI07.07.2021
LT07.07.2021
NL07.07.2021
RS07.07.2021
SE07.07.2021
BG07.10.2021
NO07.10.2021
PT08.11.2021
Former [2022/08]AT07.07.2021
FI07.07.2021
LT07.07.2021
NL07.07.2021
SE07.07.2021
BG07.10.2021
NO07.10.2021
Former [2022/07]AT07.07.2021
LT07.07.2021
NL07.07.2021
NO07.10.2021
Documents cited:Search[X]WO2007067363  (MYLAN TECHNOLOGIES INC [US], et al) [X] 1-9* page 12, line 17 - page 14, line 25; figure 3c *
International search[Y]WO9516440  (HISAMITSU PHARMACEUTICAL CO [JP], et al) [Y] 1-3, 5-11, 13-18, 21-23 * , page 6, lines 14 to 15; page 6, line 19 to page 7, line 4; page 7, lines 9 to 13; fig. 1 to 3 & US 5820877 A column 5, lines 8 to 10, 15 to 41, 49 to 59; fig. 1(a), 1(b), 2(a), 2(b), 3(a), 3(b) & JP 6-79002 A & EP 734722 A1 & AU 5659494 A & CA 2179040 A *;
 [Y]WO9706847  (HISAMITSU PHARMACEUTICAL CO [JP], et al) [Y] 1-3, 5-11, 13-18, 21-23* , page 7, lines 9 to 10; page 12, line 4 to page 13, line 6; fig. 2(a), 2(b), 3(a), 3(b), 4(a), 4(b) & US 6104950 A column 5, lines 32 to 34; column 8, line 48 to column 9, line 43; fig. 2(a), 2(b), 3(a), 3(b), 4(a), 4(b) & JP 8-10340 A & EP 846473 A1 & AU 3193395 A & CA 2229185 A *;
 [YA]JP2001514212  (Pharmaderm Laboratories, Ltd.) [Y] 1-3, 5-11, 13-18, 21-23 * , paragraph [0076]; fig. 3C & WO 1999/011247 A1 page 13, line 30 to page 14, line 6; fig. 3C & US 5993852 A & EP 1023054 A1 & AU 8968498 A & CA 2302494 A & NZ 503568 A & CN 1277551 A * [A] 4, 12, 19-20
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.